Giving thyroid hormones to critically ill patients with low thyroid hormone levels has not been proven to save lives in clinical trials, even though some small studies hint it might help certain subgroups like those with septic shock.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis of all RCTs could definitively determine whether thyroid hormone therapy reduces mortality in critically ill patients with NTIS.
A systematic review and meta-analysis of all published RCTs comparing thyroid hormone (T3 or T4) versus placebo in adult ICU patients with confirmed NTIS (T3 < 0.6 ng/mL), with primary outcome of 28-day all-cause mortality, stratified by diagnosis (sepsis, cardiac surgery, trauma), and using intention-to-treat analysis.
An RCT could determine whether T3 administration reduces mortality in septic shock patients with confirmed low T3 and FT4.
A multicenter, double-blind RCT of 800 adult septic shock patients with T3 < 0.5 ng/mL and FT4 < 0.6 ng/dL, randomized to receive intravenous T3 (10 mcg loading, then 5 mcg every 8h for 72h) or placebo, with primary outcome of 28-day mortality and secondary outcomes of vasopressor duration and organ failure.
A prospective cohort could identify whether patients receiving thyroid hormone therapy have better outcomes than those who do not, after adjusting for confounding.
A prospective cohort study of 1000 ICU patients with NTIS, recording whether they received T3/T4 therapy, matching by illness severity (SOFA score), age, and comorbidities, and comparing 90-day mortality between treated and untreated groups.
A case-control study could compare prior thyroid hormone exposure in patients who died versus those who survived in the ICU.
A case-control study comparing 200 ICU patients who died within 30 days to 200 matched survivors, assessing whether they received thyroid hormone therapy before death or discharge, adjusting for illness severity and timing of therapy.
An expert opinion can summarize existing RCTs and suggest clinical implications, but cannot determine efficacy.
A narrative review summarizing RCTs and observational studies on thyroid hormone therapy in NTIS, as presented in this document.